Early Stage Prostate Cancer 1988
Diagnosis and Choice of Therapy - Symposium Proceedings
Published in September 1989
Book
Hardback
122 pages
978-0-444-81223-0 (ISBN)
Description
Prostate cancer has become, in common with lung cancer, the most frequent cancer in men. Since the treatment of prostate cancer at an early stage offers the only possibility of a cure, the treatment modalities being radical prostatectomy of radiotherapy, it is most important to facilitate early diagnosis of this disease. Recent major technical developments have been obtained in the field of transrectal prostatic ultrasonography, with major implications in the urological practice. This book describes in detail the recent advances made in the area of ultrasonography of the prostate as well as the most up-to-date endocrine therapy which, when combined, could lead to an earlier diagnosis and earlier treatment of prostate cancer, thus permitting a curative therapy.
Prostate cancer has become, in common with lung cancer, the most frequent cancer in men. Since the treatment of prostate cancer at an early stage offers the only possibility of a cure, the treatment modalities being radical prostatectomy of radiotherapy, it is most important to facilitate early diagnosis of this disease. Recent major technical developments have been obtained in the field of transrectal prostatic ultrasonography, with major implications in the urological practice. This book describes in detail the recent advances made in the area of ultrasonography of the prostate as well as the most up-to-date endocrine therapy which, when combined, could lead to an earlier diagnosis and earlier treatment of prostate cancer, thus permitting a curative therapy.
Prostate cancer has become, in common with lung cancer, the most frequent cancer in men. Since the treatment of prostate cancer at an early stage offers the only possibility of a cure, the treatment modalities being radical prostatectomy of radiotherapy, it is most important to facilitate early diagnosis of this disease. Recent major technical developments have been obtained in the field of transrectal prostatic ultrasonography, with major implications in the urological practice. This book describes in detail the recent advances made in the area of ultrasonography of the prostate as well as the most up-to-date endocrine therapy which, when combined, could lead to an earlier diagnosis and earlier treatment of prostate cancer, thus permitting a curative therapy.
More details
Series
Language
English
Place of publication
Oxford
United Kingdom
Publishing group
Elsevier Science & Technology
Target group
College/higher education
Professional and scholarly
Dimensions
Height: 240 mm
ISBN-13
978-0-444-81223-0 (9780444812230)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Content
Foreword. Conversion of precursor adrenal steroids into potent androgens in peripheral tissues (C. Labrie, J. Simard, D. Begin, et al.). The use of transrectal ultrasound in the study of normal and abnormal anatomy of the prostate gland (F. Lee, S.T. Torp-Pedersen, D.B. Siders, et al.). The influence of transrectal ultrasound of the prostate on a private urology practice (T.A. McHugh). Temporary combination therapy with Flutamide and Tryptex as adjuvant to radical prostatectomy for the treatment of early stage prostate cancer (G. Monfette, A. Dupont and F. Labrie). Transrectal ultrasound evaluation of local disease in prostate cancer patients treated with the combination therapy (S. Pinault, J. Gagnon, G. Monfette, et al.). Histopathologic effect of combination therapy on normal prostate and prostatic adenocarcinoma (B. Tetu, F. Labrie, A. Dupont, et al.). Radiation therapy for localized prostate cancer (J. Roy). Combination therapy with Flutamide and the LHRH agonist [D-Trp 6 , des-Gly-NH 2 10 ]LHRH ethylamide in stage C prostatic carcinoma (A. Dupont, F. Labrie, G. Manhes, et al.). Combination therapy with Flutamide and castration (LHRH agonist or orchiectomy) as an alternative to transurethral resection of the prostate for urinary retention in prostate cancer (J. Emond, A. Dupont, L. Cusan, et al.). Author index.